BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34041642)

  • 1. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.
    Lopez DS; Huang D; Tsilidis KK; Canfield S; Khera M; Baillargeon JG; Kuo YF; Peek MK; Platz EA; Markides K
    Cancer Causes Control; 2021 Sep; 32(9):965-976. PubMed ID: 34041642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men.
    Lopez DS; Polychronopoulou E; Tsilidis KK; Khera M; Su LJ; Fowke JH; Peek MK; Kuo YF; Markides K; Canfield S
    Cancer Prev Res (Phila); 2021 Jul; 14(7):719-728. PubMed ID: 33879532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015.
    Lopez DS; Kim H; Polychronopoulou E; Taha S; Tsilidis KK; Villasante-Tezanos A; Peek MK; Gilani S; Khera M; Baillargeon J; Kuo YF; Canfield S
    Cancer Epidemiol; 2022 Aug; 79():102172. PubMed ID: 35523034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.
    Lopez DS; Kim H; Polychronopoulou E; Torres-Sanchez LE; Villasante-Tezanos A; Baillargeon J; Canfield S; Kuo YF
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8255-8265. PubMed ID: 37067547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.
    Lopez DS; Malagaris I; Polychronopoulou E; Tsilidis KK; Milani SA; Kristen Peek M; Villasante-Tezanos A; Alzweri L; Baillargeon J; Kuo YF; Canfield S
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):792-803. PubMed ID: 35902376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of statins and testosterone replacement therapy on incident cardiovascular disease among male hormone-related cancer survivors.
    El Haddad D; Kim H; Polychronopolou E; Baillargeon J; Villasante-Tezanos A; Kuo YF; Gilani S; Khalife WI; Lopez DS
    Res Sq; 2023 Nov; ():. PubMed ID: 37961677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database.
    Lopez DS; Huang D; Tsilidis KK; Khera M; Williams SB; Urban RJ; Panagiotou OA; Kuo YF; Baillargeon J; Farias A; Krause T
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):885-891. PubMed ID: 31498469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: Surveillance, Epidemiology, and End Results-Medicare 2007-2015.
    Hussain MR; Abdelgadir O; Polychronopoulou E; Tsilidis KK; Alzweri L; Villasante-Tezanos A; Baillargeon J; Canfield S; Kuo YF; Lopez DS
    Andrology; 2024 Feb; ():. PubMed ID: 38421134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer.
    Goldberg H; Mohsin FK; Saskin R; Kulkarni GS; Berlin A; Kenk M; Wallis CJD; Klaassen Z; Chandrasekar T; Ahmad AE; Sayyid RK; Saarela O; Penn L; Alibhai SMH; Fleshner N
    Eur Urol Focus; 2021 May; 7(3):537-545. PubMed ID: 32620539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study.
    Pandit AA; Halpern MT; Gressler LE; Kamel M; Payakachat N; Li C
    Cancer Causes Control; 2024 Apr; 35(4):647-659. PubMed ID: 38001335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
    Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
    Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insufficient Lycopene Intake Is Associated With High Risk of Prostate Cancer: A Cross-Sectional Study From the National Health and Nutrition Examination Survey (2003-2010).
    Lu Y; Edwards A; Chen Z; Tseng TS; Li M; Gonzalez GV; Zhang K
    Front Public Health; 2021; 9():792572. PubMed ID: 34966715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use in relation to prostate cancer outcomes in a population-based patient cohort study.
    Geybels MS; Wright JL; Holt SK; Kolb S; Feng Z; Stanford JL
    Prostate; 2013 Aug; 73(11):1214-22. PubMed ID: 23633265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus.
    Weeda ER; Bishu KG; Ward RC; Brown EA; Axon RN; Taber DJ; Gebregziabher M
    Am J Cardiol; 2020 May; 125(10):1492-1499. PubMed ID: 32245632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study.
    Wang K; Gerke TA; Chen X; Prosperi M
    Cancer Med; 2019 Dec; 8(17):7399-7407. PubMed ID: 31595713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
    Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
    Joentausta RM; Rannikko A; Murtola TJ
    Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with post-diagnostic metformin and statin use in a racially diverse cohort of US Veterans with advanced prostate cancer.
    Khan S; Chang SH; Hicks V; Wang M; Grubb RL; Drake BF
    Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):707-712. PubMed ID: 34811499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of testosterone therapy in men with prostate cancer.
    Morgentaler A; Caliber M
    Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
    Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
    Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.